A Randomised Phase II Clinical Trial using Targeted Radiotherapy delivered by an Yttrium-90 Radio-labelled Anti-CD66 Monoclonal Antibody with high dose mephalan compared to melphalan alone, prior to Autologous Stem Cell Transplantation for

  • Craddock, Charles (Principal Investigator)

Project Details

Short titleA Randomised Phase II Clinical Trial using Targeted Radiotherapy delivered by an Yttrium-90 Radio-labelled Anti-CD66 Monoclonal Antibody with high dose mephalan compared to melphalan alone, prior to Autologous Stem Cell Transplantation for
StatusFinished
Effective start/end date1/10/0831/03/14

Funding

  • Queen Elizabeth Hospital Birmingham